Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Comparative efficacy and safety of seven Chinese patent medicines combined with SSRIs for depressive disorder: a systematic review and network meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2025 · External reference
Unresolved reference
2022 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2018 · External reference
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses
10.1038/s41591-023-02352-1 · 2023 · External reference
Expert consensus on integrated Chinese and Western medicine for depressive disorder
10.20047/j.issn1673-7210.2021.06.002 · 2021 · External reference
Research progress of multi-target antidepressants with SSRI and 5-HT receptor subtypes activity
10.16522/j.cnki.cjph.2018.11.001 · 2018 · External reference
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis
10.1016/s0140-6736(25)01293-0 · 2025 · External reference
Combining complementary and alternative medicine (CAM) with conventional treatments for major depressive disorder
10.1007/978-981-97-4402-2_6 · 2024 · External reference
Clinical practice guideline for Chinese patent medicine in the treatment of depressive disorder (2022)
2023 · External reference
Unresolved reference
2025 · External reference
Research progress of selective serotonin reuptake inhibitor combined therapy in treatment-resistant depression
10.3867/j.issn.1000-3002.2022.10.007 · 2022 · External reference
Clinical use of Hypericum perforatum (St John's wort) in depression: a meta-analysis
10.1016/j.jad.2016.12.048 · 2017 · External reference
The effectiveness and safety of acupuncture for depression: an overview of meta-analyses
10.1016/j.ctim.2019.102202 · 2020 · External reference
Dance/movement therapy in psychotic disorders and eating disorders: a systematic review
10.3389/fpsyt.2026.1802394 · 2026 · External reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
10.1136/bmj.l4898 · 2019 · External reference
Clinical study of Bajitian oligosaccharide capsule combined with sertraline in the treatment of depression
2018 · External reference
Clinical effect observation of Shugan Jieyu Capsule combined with sertraline in the treatment of depression
10.13638/j.issn.1671-4040.2023.24.027 · 2023 · External reference
Efficacy of Bajitian oligosaccharide capsule combined with sertraline in the treatment of depression
2019 · External reference
Controlled study of sertraline combined with Shugan Jieyu Capsule in the treatment of recurrent depressive disorder
2016 · External reference
Efficacy of sertraline combined with Wuling Capsule in depression and its effect on patient cognitive function
2025 · External reference
Clinical observation of Jieyu Wan combined with sertraline hydrochloride tablets in the treatment of depression
2024 · External reference
Clinical study of Jieyu Wan combined with sertraline in the treatment of depression
2019 · External reference
Clinical efficacy observation of sertraline combined with Wuling Capsule in depression
2016 · External reference
Xiaoyao Pill combined with sertraline in the treatment of depression: 40 cases
2013 · External reference
Efficacy observation of Xiaoyao Wan combined with sertraline in liver-qi stagnation depression: 30 cases
2022 · External reference
A control study of sertraline combined with wuling capsule in the treatment of anxiety and depression comorbidity
2009 · External reference
Effect study of fluoxetine combined with Shugan Jieyu Capsule in the treatment of depression
2025 · External reference
Effect of fluoxetine combined with Shugan Jieyu capsule on therapeutic efficacy and cognitive function in patients with depression. [Dissertation]
2015 · External reference
Effect of Shugan Jieyu capsule combined with fluoxetine on clinical efficacy and heart rate variability in patients with depression
10.13457/j.cnki.jncm.2021.16.017 · 2021 · External reference
Efficacy and safety of fluoxetine combined with Shugan Jieyu capsule in the treatment of depression with insomnia
2016 · External reference
Effect of fluoxetine combined with Shugan Jieyu capsule on depression and heart rate variability in patients
2023 · External reference
Shugan Jieyu capsule combined with fluoxetine in the treatment of depression: a clinical observation of 34 cases
2012 · External reference
Effect of Jieyu Pill combined with fluoxetine on neurotransmitters in patients with depression
10.16041/j.cnki.cn15-1175.2025.10.008 · 2025 · External reference
Controlled study of Jieyu Pill combined with fluoxetine for major depressive disorder
10.13342/j.cnki.cjhp.2010.08.013 · 2010 · External reference
Clinical study of Tianmeng Oral Liquid combined with fluoxetine in treatment of depression and its effect on hypodynamic symptom
10.7501/j.issn.0253-2670.2023.10.019 · 2023 · External reference
Clinical efficacy and pharmacological mechanism of Danzhi Xiaoyao Powder combined with fluoxetine hydrochloride capsules in the treatment of patients with depression
2021 · External reference
A controlled study of Xiaoyao Pills combined with citalopram in the treatment of depression
2007 · External reference
Observation on the effect of Shugan Jieyu capsules combined with paroxetine in the treatment of first-episode depression
2016 · External reference
Effect of Shugan Jieyu capsules combined with paroxetine on neurological function rehabilitation in patients with depression
2021 · External reference
Effects of Jieyu Pills combined with citalopram on NE, 5-HT and BDNF levels and social function in patients with refractory depression
2019 · External reference
Clinical effect of Wuling capsules combined with escitalopram in the treatment of mild to moderate depressive episodes
2021 · External reference
Efficacy of Jieyu Pills combined with escitalopram in the treatment of depression with liver stagnation and spleen deficiency and its effect on pro-inflammatory factor levels
2025 · External reference
A controlled study of citalopram combined with Shugan Jieyu capsules in the treatment of depression
2013 · External reference
Clinical analysis of Shugan Jieyu capsules combined with escitalopram in the treatment of refractory depression
2023 · External reference
Observation on the effect of Shugan Jieyu capsules combined with escitalopram in the treatment of depression
10.3969/j.issn.1006-5180.2016.21.020 · 2016 · External reference
Clinical study of Shugan Jieyu capsules combined with escitalopram in the treatment of mild to moderate unipolar depression
10.13457/j.cnki.jncm.2024.11.006 · 2024 · External reference
A prospective controlled study of Shugan Jieyu capsules combined with escitalopram in the treatment of refractory depression
2024 · External reference
Clinical efficacy and safety of escitalopram combined with Shugan Jieyu capsules in the treatment of depression
10.3760/cma.j.issn.1007-1245.2016.14.044 · 2016 · External reference
Efficacy analysis of Shugan Jieyu capsules combined with escitalopram in the treatment of depression complicated with anxiety
2022 · External reference
Efficacy of shugan jieyu capsules combined with escitalopram in the treatment of refractory depression
2020 · External reference
Observation on the efficacy of shugan jieyu capsules combined with citalopram in the treatment of depression with liver stagnation and spleen deficiency
2017 · External reference
Clinical study of shugan jieyu capsules combined with escitalopram oxalate in the treatment of depression
2020 · External reference
Clinical observation of shugan jieyu capsules combined with escitalopram oxalate tablets in the treatment of depression
2016 · External reference
Analysis of shugan jieyu capsules combined with escitalopram oxalate in the treatment of severe depression
2013 · External reference
Efficacy of shugan jieyu capsules combined with escitalopram oxalate in the treatment of depression and its effect on neurotransmitter levels
2025 · External reference
Observation on the efficacy of shugan jieyu capsules combined with escitalopram oxalate in the treatment of depression complicated with anxiety
2018 · External reference
Observation on the efficacy of Morinda officinalis oligosaccharide capsules combined with escitalopram oxalate tablets in the treatment of depression
2017 · External reference
Unresolved reference
2024 · External reference
Clinical effect analysis of shugan jieyu capsules combined with escitalopram in the treatment of refractory depression
2024 · External reference
A controlled study of tianmeng oral liquid combined with escitalopram in the treatment of patients with depressive episodes
2016 · External reference
Observation on the efficacy of tianmeng oral liquid combined with escitalopram oxalate in the treatment of depression
2016 · External reference
Unresolved reference
2017 · External reference
A clinical controlled study of paroxetine plus xiaoyao pills in the treatment of depression
2009 · External reference
Controlled observation on the synergistic treatment of depression with chinese medicine jieyu pills combined with paroxetine
2012 · External reference
Xiaoyao pills combined with paroxetine in the treatment of depression: 38 cases
2012 · External reference
Observation on the efficacy of shugan jieyu capsules combined with paroxetine in the treatment of depression
10.3969/j.issn.1006-5687.2019.04.015 · 2019 · External reference
Clinical observation of Morinda officinalis oligosaccharide combined with paroxetine in the treatment of depression
2022 · External reference
Shugan jieyu capsules combined with paroxetine tablets in the treatment of depression: 30 cases
10.1515/9783110417661 · 2015 · External reference
Clinical evaluation of Morinda officinalis oligosaccharide combined with paroxetine in the treatment of depression
2020 · External reference
Clinical effect of shugan-jieyu capsules combined with paroxetine on depression
2017 · External reference
Clinical observation of shugan jieyu capsules combined with paroxetine in the treatment of patients with depressive episodes
10.19621/j.cnki.11-3555/r.2021.2028 · 2021 · External reference
A clinical controlled study of paroxetine hydrochloride combined with danzhi xiaoyao pills in the treatment of depression with anxiety
2017 · External reference
Clinical efficacy of jiawei xiaoyao pills combined with paroxetine in the treatment of reactive depression
2014 · External reference
Clinical efficacy observation of wuling capsules combined with paroxetine hydrochloride in the treatment of mild to moderate depression
2014 · External reference
Clinical observation of paroxetine hydrochloride combined with yangxue qingnao granules in the treatment of patients with depression and insomnia
2018 · External reference
Efficacy of shugan jieyu capsules combined with fluvoxamine in the treatment of depression and its effect on sleep
2016 · External reference
Clinical observation of shugan jieyu capsules combined with fluvoxamine in the treatment of depression with liver stagnation and spleen deficiency
2015 · External reference
Clinical study of wuling capsules combined with fluvoxamine in the treatment of depression
2024 · External reference
Clinical study of escitalopram combined with shugan jieyu capsules in the treatment of depression
2016 · External reference
Clinical observation of fluvoxamine combined with xiaoyao pills in the treatment of depression
2012 · External reference
Unresolved reference
2020 · External reference
Efficacy and safety of Morinda officinalis oligosaccharide capsules for depressive disorder: a systematic review and meta-analysis
10.1590/1516-4446-2020-0945 · 2021 · External reference
Effects of suanzaoren decoction combined with tianmeng oral liquid on neuroendocrine, cognitive function and deep sleep in patients with sleep disorders
10.13193/j.issn.1673-7717.2020.03.055 · 2020 · External reference
Efficacy and safety of traditional chinese medicine combined with SSRIs in the treatment of depression: a meta-analysis
10.3969/j.issn.1671-945x.2026.04.002 · 2026 · External reference
